Variants such as SOD2 rs4880, GSTP1, GSTO1, PON1, and NOS3 have been associated with reduced enzymatic activity, impaired detoxification of ROS, and worsened COVID-19 severity or post-acute sequelae (Eid et al., 2024). This evidence concerns the gene GSTO1 and COVID-19.